Iodine Status During Pregnancy and Its Effect on Infant Development. (Mommy'sFood)

April 14, 2023 updated by: Marian Kjellevold, National Institute of Nutrition and Seafood Research, Norway

Iodine Status During Pregnancy and Its Effect on Infant Development; a Randomized Intervention Study With Cod

The overall aim of the present project is to investigate if intake of cod in pregnancy has impact on infant development up to 12 month. 142 pregnant women will be allocated into two groups, one counsuming cod two times the week for four months and one group will continue to follow their habitual diet. To study this, urine samples, dietary data and blood samples from the mother and from the infant, as well as data on neurodevelopment and cognitive functioning will be collected at several time points.

Study Overview

Status

Completed

Conditions

Detailed Description

The World Health Organization considers iodine deficiency to be "the single most important preventable cause of brain damage" worldwide. The effect of severe iodine deficiency is well documented. Pregnant and nursing mothers have increased requirements and are thus a vulnerable group. Iodine is a key component of thyroid hormones that are critical for normal development of the brain and nervous system in utero. There is little data on the effect of mild- and moderate iodine deficiency. Results from the Norwegian Mother and Child cohort (n = about 62,000) shows that only 22% of the participants had an iodine intake, estimated from food frequency questionnaire, that meets the recommendations of WHO / UNICEF / ICCIDD. Urine samples from a sub-sample (n = 119) confirmed suboptimal iodine status. The results are consistent with recent data from a NIFES study of about 100 women from the municipality of Fjell, which reviled suboptimal iodine status both in pregnancy and three months after birth. Preliminary results from the study Little in Norway, where NIFES measured the iodine status in approximately 1,000 pregnant from across the country, is also consistent with these investigations. Dairy products is highlighted as the main source of iodine for the participants in the Norwegian Mother and Child cohort, while lean fish is the food group that has the highest Iodine levels. In this article, the positive effect of seafood was explained by the fatty acids EPA and DHA, while the latest publication suggests that the effect of an adequate intake of seafood during pregnancy are more complex, and that the high iodine levels in seafood may also be important. Based on this knowledge, there is a need for an intervention study where pregnant consume cod regularly over a longer period and where the children are followed up over time. Thus, in the present project the researchers will investigate if intake of cod in pregnancy has impact on infant development up to 12 month. 142 pregnant women will be allocated into two groups, one consuming cod two times the week for four months and one group will eat as normal. Urine samples, dietary data and blood samples from the mother and from the infant, as well as data on neurodevelopment and cognitive functioning will be collected at several time points.

Study Type

Interventional

Enrollment (Actual)

137

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bergen, Norway, 5817
        • Institute of Marine Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 50 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • ≤ gestational week 19,
  • prim parous,
  • singleton pregnancy,
  • Norwegian speaking and / or understand Norwegian writing due to all validated tests of the child will be in Norwegian.

Exclusion Criteria:

  • allergies to fish,
  • chronic diseases known to affect iodine status (Graves' disease, Thyroiditis, Thyroid Nodules, known hypothyroidism, known hyperthyroidism).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Intervention with cod 200 grams two times the week for four months.
The overall aim of the present project is to investigate if intake of cod in pregnancy has impact on infant development up to 12 month.
Experimental: Control group
Control group which will continue to eat their habitual diet.
The overall aim of the present project is to investigate if intake of cod in pregnancy has impact on infant development up to 12 month.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in Urinary iodine concentration between groups
Time Frame: 16 weeks
A collection sample of 1 ml of homogenized spot morning urin collected on six consecutive days will be analyzed for iodine (umol/L) before and after the intervention in both Groups. Groups will be compared in relation to delta-values before and after intervention/no intervention.
16 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in Bayley Scale of Infant Developmental scores between groups
Time Frame: 17 months
Student's t-test to compare the means between the groups.
17 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in Ages and Stages Questionnaire: Social-Emotional (ASQ:SE)
Time Frame: Infant age 3, 6 and 11 months
We compare scores between groups using linear mixed effects models and examined whether iodine status post intervention mediated the effect on child development.
Infant age 3, 6 and 11 months
Difference in Ages and Stages Questionnaire 2nd. edition (ASQ-2)
Time Frame: Infant age 3, 6 and 11 months
We compare scores between groups using linear mixed effects models and examined whether iodine status post intervention mediated the effect on child development.
Infant age 3, 6 and 11 months
Extended follow up at five-six years - 5-15R (FTF/Five To Fifteen) questionnaire
Time Frame: Child age five-six years
We compare scores between groups 5-15R (FTF/Five To Fifteen) questionnaire
Child age five-six years
Extended follow up at five-six years - Difference in Ages and Stages Questionnaire Social-Emotional (ASQ:SE)
Time Frame: Child age five-six years
We compare scores between groups in Ages and Stages Questionnaire: Social-Emotional (ASQ:SE)
Child age five-six years
Extended follow up at five-six years - Strengths and Difficulties Questionnaire
Time Frame: Child age five-six years
We compare scores between groups in Strengths and Difficulties Questionnaire
Child age five-six years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Marian Kjellevold, PhD, Institute of Marine Research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2015

Primary Completion (Actual)

September 1, 2018

Study Completion (Actual)

September 17, 2018

Study Registration Dates

First Submitted

November 17, 2015

First Submitted That Met QC Criteria

November 18, 2015

First Posted (Estimate)

November 20, 2015

Study Record Updates

Last Update Posted (Actual)

April 18, 2023

Last Update Submitted That Met QC Criteria

April 14, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2015/879

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diet

Clinical Trials on Intervention group

3
Subscribe